Cancer

PillBot™: Micro-robotics now inside the Human Body

HAYWARD, Calif., July 2, 2024 /PRNewswire/ -- Endiatx, a pioneering Silicon Valley medical technology company, is shaping the future of…

7 months ago

Digital Pathology Scanner Market Size to Grow USD 1,137 Million by 2030 at a CAGR of 10.31% | Valuates Reports

BANGALORE, India, July 2, 2024 /PRNewswire/ -- Digital Pathology Scanner Market is Segmented by Type (Fluorescence, Brightfield), by Application (Scientific Research,…

7 months ago

Body Vision Medical Announces Departure of David Webster as CEO and Appoints Matt Baker as Successor

CAMPBELL, Calif., July 2, 2024 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven intraoperative image guidance, announced today that…

7 months ago

Health In Tech, Adena Health, and OSU Health Plan Solutions Partner to Bring Affordable Level-Funded Health Plans to Ohio Employers

STUART, Fla., July 2, 2024 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and reimagines…

7 months ago

Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024

July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival…

7 months ago

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

7 months ago

Vaxcyte Appoints John Furey to Board of Directors

SAN CARLOS, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines…

7 months ago

Mainz Biomed Provides Half Year 2024 Corporate Update

Industry Leading Clinical Data Position the Company for FDA Premarket Approval StudyBERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE…

7 months ago

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology…

7 months ago

Scientific Presentations Highlight OGM’s Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations

At a sponsored workshop, Su Yang from The University of Texas MD Anderson Cancer Center will present case studies that…

7 months ago